Cure Logo
false

Partnered Events

Cure Celebrates ARPA-H's Transformational Investments in Women's Health

December 5, 2024
4:00 PM ET
345 Park Avenue South, NY, NY 10010

Introduction

Join Cure in celebrating the New York-based awardees of ARPA-H's Sprint for Women's Health

As the first major deliverable of the White House Initiative on Women’s Health Research, the ARPA-H Sprint for Women's Health is providing more than $113 million in non-dilutive capital to 24 awardees to seed innovation and provide a launchpad for innovation in women's health.

The initiative is conducted in collaboration with the Investor Catalyst Hub of ARPANET-H, the agency’s nationwide health innovation network that connects people, innovators and institutions – including Cure – to accelerate better health outcomes for everyone.

Register here for virtual attendance.

Speakers

Speakers

Hosted by Seema Kumar, Chief Executive Officer, Cure

Renee Wegrzyn, PhD, Director, ARPA-H

Jenica Patterson, PhD, Portfolio Lead Project Accelerator Transition Innovation Office, ARPA-H

Katherine Andersen, Head of Life Science & Healthcare, HSBC Innovation Banking US

Viq Pervaaz, Senior Vice President, New York City Economic Development Corporation

Presentations from New York-based ARPA-H’s Sprint for Women’s Health Awardees

  • Alexandra Sakatos, PhD, Ancilia Biosciences

  • Sandra Milligan, MD, JD, Aspira Women's Health

  • Piraye Beim, PhD, Celmatix

  • Christian Kramme, PhD, Gameto

  • Elisa Riedo PhD, Glaucus

Sprint for Women's Health Sparks Innovation

The Sprint for Women's Health awardees, selected from more than 1,700 entries from 35 countries, span emerging startups to established global innovators.

Notably, 30 percent of the awardees are first-time government funding recipients, 39 percent employ fewer than 50 people, and more than 70 percent are led by women.

The funding is designed to support both early-stage “spark” projects and later-stage “launchpad” initiatives, with the latter aiming for commercialization within two years, ensuring timely access to new solutions for women's health needs.